Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators.
Moderna’s stock experienced a significant increase, more than doubling on Wednesday. This surge followed the announcement of initial positive results from a study on an experimental cancer treatment. If approved, this treatment would be the first of its kind.
- Moderna shares more than doubled on Wednesday.
- The company announced initial results from an experimental cancer treatment study.
- The treatment could be the first of its kind if approved.
Write a comment